Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation (Q35207758)

7 August 2017

1 reference

title

Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation (English)

1 reference

7 August 2017

author

Jean-Charles Fruchart

3

0 references

Christophe Blanquart

object named as

Christophe Blanquart

1

0 references

Bart Staels

object named as

Bart Staels

4

0 references

Corine Glineur

5

object named as

Corine Glineur

1 reference

7 August 2017

Olivier Barbier

2

1 reference

7 August 2017

publication date

1 June 2003

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

7 August 2017

published in

1 reference

7 August 2017

volume

85

1 reference

7 August 2017

issue

2-5

1 reference

7 August 2017

page(s)

267-273

1 reference

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Nuclear hormone receptors and gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Structure and specificity of nuclear receptor-coactivator interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Interdomain communication regulating ligand binding by PPAR-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Protein regulation: tag wrestling with relatives of ubiquitin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Peroxisome Proliferator-activated Receptor α Activation Modulates Cellular Redox Status, Represses Nuclear Factor-κB Signaling, and Reduces Inflammatory Cytokine Production in Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

The role of PPARs in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900214-0

7 January 2021

10.1016/S0960-0760(03)00214-0

Identifiers

DOI

1 reference

7 August 2017

1 reference